A 3-year national DRL for CT in hybrid imaging study in Kuwait health environment-impact and implementation.

BJR open Pub Date : 2024-10-04 eCollection Date: 2024-01-01 DOI:10.1093/bjro/tzae032
Michael Masoomi, Latifah Al-Kandari, Iman Al-Shammeri, Hany Elrahman, Jehan Al-Shammeri
{"title":"A 3-year national DRL for CT in hybrid imaging study in Kuwait health environment-impact and implementation.","authors":"Michael Masoomi, Latifah Al-Kandari, Iman Al-Shammeri, Hany Elrahman, Jehan Al-Shammeri","doi":"10.1093/bjro/tzae032","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Diagnostic reference levels (DRLs) for CT in PET-CT are limited, and published DRLs from other countries may not be directly applicable to the State of Kuwait (KW). The authors aimed to carry out the final phase of a 3-year study on DRLs in KW, supporting optimization and dose reduction as imaging technology advances.</p><p><strong>Methods: </strong>In this cohort study, 400 adult oncology patients from 8 PET-CT centres were included, following the same procedures as in the first (2018) and second (2020) years, in accordance with the MOH-KW Ethical Committee's recommendations. The CT dose index (CTDIvol), dose-length product (DLP), and scan length were recorded, and the median, mean, standard deviation, as well as the 75th and 25th percentiles, along with the whole-body (WB) effective dose (ED), were calculated. Comparative studies were conducted to track implementation and identify any shortfalls.</p><p><strong>Results: </strong>In this study, half-body (HB) and WB scans accounted for 66% and 34% of the total 400 cases, respectively. The proposed local DRL practice among the 8 centres in the 2022 study exhibited a maximum variation of 25%, showing a 30% improvement over 2020. The achievable local DRL remained consistent with 2020 levels. Comparative results of the third quartile DLP (476 mGy cm) and CTDIvol (4 mGy) values for 2022 indicated lower values for the third phase (400 entries) compared to 2020, with a 1.5-fold variation in DLP. The calculated ED for WB scans ranged from 2.6 to 7.1 mSv, with mean values of 4.7 ± 1.25 mSv, using a conversion factor (<i>k</i> = 0.0093 mSv/mGy/cm). The 2022 proposed national diagnostic reference levels (NDRLs) for HB (469 mGy cm, 4.0 mGy) were lower than the Swiss National Data (620 mGy cm, 6.0 mGy) and France (628 mGy cm, 6.6 mGy), but slightly higher than those of the United Kingdom (400 mGy cm, 4.3 mGy), despite the Swiss having about 5000 entries, France 1000 entries, and the United Kingdom 370 HB entries.</p><p><strong>Conclusions: </strong>There was a 11.1% continuous improvement in NDRL for 2022 compared to 9.1% in 2020 and 13% in 2018, demonstrating a trend of enhanced optimization.</p><p><strong>Advances in knowledge: </strong>The data established a trend of NDRL for WBCT (PET-CT) that can serve as a national databank for ongoing optimization. This promotes improvements in patient protection and quality care within the clinical environment of the State of Kuwait, aligning with the strategic goals of Kuwait Vision-2035.</p>","PeriodicalId":72419,"journal":{"name":"BJR open","volume":"6 1","pages":"tzae032"},"PeriodicalIF":0.0000,"publicationDate":"2024-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11495866/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BJR open","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/bjro/tzae032","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Diagnostic reference levels (DRLs) for CT in PET-CT are limited, and published DRLs from other countries may not be directly applicable to the State of Kuwait (KW). The authors aimed to carry out the final phase of a 3-year study on DRLs in KW, supporting optimization and dose reduction as imaging technology advances.

Methods: In this cohort study, 400 adult oncology patients from 8 PET-CT centres were included, following the same procedures as in the first (2018) and second (2020) years, in accordance with the MOH-KW Ethical Committee's recommendations. The CT dose index (CTDIvol), dose-length product (DLP), and scan length were recorded, and the median, mean, standard deviation, as well as the 75th and 25th percentiles, along with the whole-body (WB) effective dose (ED), were calculated. Comparative studies were conducted to track implementation and identify any shortfalls.

Results: In this study, half-body (HB) and WB scans accounted for 66% and 34% of the total 400 cases, respectively. The proposed local DRL practice among the 8 centres in the 2022 study exhibited a maximum variation of 25%, showing a 30% improvement over 2020. The achievable local DRL remained consistent with 2020 levels. Comparative results of the third quartile DLP (476 mGy cm) and CTDIvol (4 mGy) values for 2022 indicated lower values for the third phase (400 entries) compared to 2020, with a 1.5-fold variation in DLP. The calculated ED for WB scans ranged from 2.6 to 7.1 mSv, with mean values of 4.7 ± 1.25 mSv, using a conversion factor (k = 0.0093 mSv/mGy/cm). The 2022 proposed national diagnostic reference levels (NDRLs) for HB (469 mGy cm, 4.0 mGy) were lower than the Swiss National Data (620 mGy cm, 6.0 mGy) and France (628 mGy cm, 6.6 mGy), but slightly higher than those of the United Kingdom (400 mGy cm, 4.3 mGy), despite the Swiss having about 5000 entries, France 1000 entries, and the United Kingdom 370 HB entries.

Conclusions: There was a 11.1% continuous improvement in NDRL for 2022 compared to 9.1% in 2020 and 13% in 2018, demonstrating a trend of enhanced optimization.

Advances in knowledge: The data established a trend of NDRL for WBCT (PET-CT) that can serve as a national databank for ongoing optimization. This promotes improvements in patient protection and quality care within the clinical environment of the State of Kuwait, aligning with the strategic goals of Kuwait Vision-2035.

在科威特卫生环境中开展为期 3 年的混合成像 CT 国家 DRL 研究--影响与实施。
目的:PET-CT 的 CT 诊断参考水平(DRLs)有限,其他国家公布的 DRLs 可能无法直接适用于科威特国(KW)。作者的目的是在科威特开展为期 3 年的 DRLs 研究的最后阶段,随着成像技术的进步,为优化和减少剂量提供支持:在这项队列研究中,纳入了来自 8 个 PET-CT 中心的 400 名成人肿瘤患者,按照 MOH-KW 伦理委员会的建议,采用了与第一年(2018 年)和第二年(2020 年)相同的程序。记录了 CT 剂量指数(CTDIvol)、剂量长度乘积(DLP)和扫描长度,并计算了中位数、平均值、标准偏差、第 75 百分位数和第 25 百分位数以及全身有效剂量(ED)。还进行了比较研究,以跟踪实施情况并找出不足之处:在这项研究中,半身扫描(HB)和全身扫描分别占总计 400 个病例的 66% 和 34%。在 2022 年的研究中,8 个中心建议的本地 DRL 实践显示最大差异为 25%,比 2020 年提高了 30%。当地可实现的 DRL 与 2020 年的水平保持一致。2022 年第三四分位数 DLP(476 mGy cm)和 CTDIvol(4 mGy)值的比较结果显示,第三阶段(400 个条目)的值比 2020 年低,DLP 的差异为 1.5 倍。使用换算系数(k = 0.0093 mSv/mGy/cm)计算得出的 WB 扫描 ED 值介于 2.6 至 7.1 mSv 之间,平均值为 4.7 ± 1.25 mSv。2022 年提出的国家诊断参考水平(NDRLs)低于瑞士国家数据(620 mGy cm,6.0 mGy)和法国(628 mGy cm,6.6 mGy),但略高于英国(400 mGy cm,4.3 mGy),尽管瑞士有大约 5000 个条目,法国有 1000 个条目,英国有 370 个 HB 条目:2022 年的 NDRL 持续改善了 11.1%,而 2020 年为 9.1%,2018 年为 13%,显示出优化增强的趋势:该数据建立了 WBCT(PET-CT)的 NDRL 趋势,可作为持续优化的国家数据库。这促进了科威特国临床环境中患者保护和优质护理的改善,符合《科威特愿景-2035》的战略目标。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
审稿时长
18 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信